Skip to main content
. 2017 Nov 29;15(3):250–257. doi: 10.1177/1479972317743759

Table 1.

Baseline characteristics of studied population.a

Variables N = 121
Age (years), mean (SD) 70 9.0
Age group (years), n (%)
 <65 32 26.45
 65–74 47 38.84
 ≥75 42 43.71
Male sex, n (%) 112 92.6
Educational level, n (%)
 6 years or lower 59 48.76
 7–12 years 28 23.14
 >12 years 34 28.10
Smoking status, n (%)
 Never smoker 7 5.79
 Ex-smoker 104 85.95
 Current smoker 10 8.26
Severity of COPD, n (%)
 Mild 31 25.62
 Moderate 69 57.02
 Severe 21 17.36
MMRC scale, mean (SD) 0.69 1.08
Comorbid diseases, n (%)
 Diabetes mellitus 12 9.92
 Hypertension 46 38.02
 Dyslipidemia 10 8.26
 Chronic arthritis 10 8.26
 Cancer 6 4.96
Regular medication uses, n (%)
 Inhaled corticosteroid 113 93.39
 Systemic steroid 2 1.65
 Oral hypoglycemic drugs 7 5.79
 Statin 13 10.74
 NSAIDs 1 0.83
History of fall at least two times over the past 12 months, n (%) 3 0.89
Barthel scores, mean (SD) 19.9 1
Chula IADLs scores, mean (SD) 8.98 0.18
Nonelective admission over the past 12 months, n (%) 32 26.45
BMI (kg/m2), n (%)
 Underweight (<18.5) 19 15.7
 Normal and over weight (18.5–24.9) 65 53.72
 Obesity (>25) 37 30.58
MAP (mmHg), mean (SD) 95.96 10.68
6-MWD (m), mean (SD) 423.39 73.67
Gait speed (m/s), mean (SD) 1.18 0.2
Handgrip strength (kg), mean (SD)
 Male 26.65 6.02
 Female 21.22 3.43
Appendicular skeletal mass index (kg/m2), mean (SD)
 Male 7.1 0.89
 Female 6.25 0.46
Osteoporosis, n (%) 45 37.19
Sarcopenia, n (%) 29 24

COPD: chronic obstructive pulmonary disease; NSAIDs: nonsteroidal anti-inflammatory drugs; IADL: instrumental activities of daily living; BMI: body mass index; MAP: mean arterial blood pressure; SD: standard deviation; osteoporosis: defined when T-score of femoral neck or lumbar spine ≤−2.5 SD; 6-MWD: 6-min walk distance; MMRC scale: Modified Medical Research Council scale (it was available in 116 patients).

aAppendicular skeletal mass was calculated by summing the muscle masses of the four limbs.